Q3 2024 Mineralys Therapeutics Inc Earnings Call

Yahoo FinanceNov 12 10:12 ET

Mineralys Therapeutics | 8-K: Mineralys Therapeutics Reports Third Quarter 2024 Financial Results and Provides Corporate Update

SECNov 12 09:45 ET

Mineralys Therapeutics | 10-Q: Q3 2024 Earnings Report

SECNov 12 09:32 ET · Announcements

Wells Fargo Maintains Mineralys Therapeutics(MLYS.US) With Buy Rating, Announces Target Price $26

Moomoo NewsNov 12 06:31 ET · Ratings

Buy Rating on Mineralys Therapeutics Driven by Lorundrostat's Potential in Hypertension Treatment

TipRanksNov 12 06:17 ET · Ratings

Analysts Offer Insights on Healthcare Companies: Mineralys Therapeutics, Inc. (MLYS) and Hookipa Pharma (HOOK)

TipRanksNov 12 06:10 ET · Ratings